Cleopatra Hospitals Group results, Q2 2024
Net profit, assets, equity and cash flow for Q2 2024, against the same period a year earlier, from the published financial statements.
Net profit143 millionEGP · +47.9% vs the same period a year earlier
Total assets5.68 billionEGP · +51.2% vs the same period a year earlier
Shareholders' equity2.72 billionEGP · +24.7% vs the same period a year earlier
Operating cash flow-84.72 millionEGP · −1391.0% vs the same period a year earlier
In short
- Cleopatra Hospitals Group's net profit for Q2 2024 was about 143 million EGP, up +47.9% from 96.65 million EGP in Q2 2023.
- Total assets at the end of Q2 2024 were about 5.68 billion EGP, and shareholders' equity about 2.72 billion EGP.
- Operating cash flow for Q2 2024 was negative at 84.72 million EGP.
Key lines against the same period a year earlier
This periodQ2 2023Change
Net profit143 million96.65 million+47.9%
Gross profit473 million295 million+60.3%
Total assets5.68 billion3.75 billion+51.2%
Total liabilities2.96 billion1.57 billion+88.0%
Shareholders' equity2.72 billion2.18 billion+24.7%
Total liabilities and equity5.68 billion3.75 billion+51.2%
Operating cash flow-84.72 million6.56 million−1391.0%
Investing cash flow-202 million-188 million−7.1%
Financing cash flow216 million94.91 million+127.9%
Net change in cash-70.26 million-87 million+19.2%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Cleopatra Hospitals Group's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy